The number of transluminal coronary angioplasties performed in France is forecasted to rise steadily from 41.5 units per hundred thousand persons in 2024 to 71.4 in 2028. This projected growth indicates a healthy year-on-year increase of approximately 15%, with a compound annual growth rate (CAGR) of about 14% based on the forecasted data. In 2023, the corresponding figure stood at 34 units, marking a robust upward trajectory.

Innovations in medical technology and techniques could further augment these growth figures.
Increasing prevalence of cardiovascular diseases in aging populations could drive demand.
Healthcare policy and reimbursement changes may impact future procedural volumes.